Publication date: Jul 23, 2025
(A) Axial view with uptake in basal lateral and basal septal regions, surrounding mitral annulus. A control group that included subjects with a history of severe COVID but without cardiopulmonary symptoms at recruitment was also characterized. (E) Sagittal view with increased uptake in basal segments surrounding mitral valve annulus. (C) Axial view with increased 18F-FDG uptake in regions surrounding mitral annulus. Representative examples show hybrid, fused PET/MRI in patients with findings suggestive of periannular uptake. Ninety percent of subjects presented abnormalities in DECT, including pulmonary infiltrates and abnormal perfusion. (B) T2 values are globally increased, especially in basal septum.
| Concepts | Keywords |
|---|---|
| Cardiology | Abnormal |
| July | Basal |
| Ninety | Cardiopulmonary |
| Pandemic | Covid |
| Suv | Findings |
| Increased | |
| Infection | |
| Long | |
| Mitral | |
| Mr | |
| Pet | |
| Pulmonary | |
| Subjects | |
| Symptoms | |
| Uptake |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | pulmonary hypertension |
| disease | MESH | mitral regurgitation |
| disease | MESH | heart failure |
| disease | MESH | infection persistent |
| disease | IDO | history |
| disease | MESH | inflammation |
| disease | MESH | abnormalities |
| disease | IDO | infection |
| disease | MESH | infections |
| drug | DRUGBANK | Acetohydroxamic acid |
| disease | MESH | Long COVID |
| disease | MESH | Pulmonary Diseases |
| drug | DRUGBANK | Fludeoxyglucose F-18 |